NCT00077519View on ClinicalTrials.gov

Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Pancreatic Cancer
Interventions
DRUG

tipifarnib

RADIATION

radiation therapy

Trial Locations (1)

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT00077519 - Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter